Nektar Therapeutics (NKTR) Amortizatization of Intangibles (2024 - 2026)

Nektar Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$1.7 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 25.6% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$5.9 million (up 22.02% YoY), while the FY2025 annual figure was -$5.5 million, up 40.36% from the prior year.
• Amortizatization of Intangibles was -$1.7 million for Q1 2026 at Nektar Therapeutics, up from -$1.9 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of -$869000.0 in Q2 2025 to a low of -$3.1 million in Q1 2024.
• Historically, Amortizatization of Intangibles has averaged -$1.8 million across 3 years, with a median of -$1.7 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles soared 66.37% in 2025, then decreased 25.6% in 2026.
• A 3-year view of Amortizatization of Intangibles shows it stood at -$1.5 million in 2024, then decreased by 23.08% to -$1.9 million in 2025, then increased by 11.92% to -$1.7 million in 2026.
• The last three Amortizatization of Intangibles figures came in at -$1.7 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.